Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Sarah Milgrom

Concepts (347)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease
34
2024
133
9.520
 Why?
Radiotherapy, Intensity-Modulated
15
2024
129
3.240
 Why?
Positron Emission Tomography Computed Tomography
14
2023
87
2.920
 Why?
Tumor Burden
6
2024
287
2.280
 Why?
Fluorodeoxyglucose F18
7
2023
128
2.280
 Why?
Antineoplastic Combined Chemotherapy Protocols
30
2024
1560
2.160
 Why?
Lymphoma
9
2024
198
2.070
 Why?
Radiotherapy
12
2020
185
1.920
 Why?
Central Nervous System Neoplasms
9
2021
149
1.840
 Why?
Radiation Injuries
8
2021
135
1.820
 Why?
Radiopharmaceuticals
6
2023
168
1.730
 Why?
Radiotherapy Planning, Computer-Assisted
12
2024
124
1.690
 Why?
Lymphoma, Non-Hodgkin
6
2024
79
1.600
 Why?
Neoplasm Staging
30
2021
1282
1.490
 Why?
Lymphoma, Large B-Cell, Diffuse
8
2024
115
1.450
 Why?
Radiotherapy Dosage
16
2024
251
1.340
 Why?
Neoplasm Recurrence, Local
13
2023
957
1.340
 Why?
Sarcoma
2
2023
175
1.300
 Why?
Salvage Therapy
11
2024
136
1.260
 Why?
Endometrial Neoplasms
4
2014
161
1.190
 Why?
Mediastinal Neoplasms
5
2021
39
1.180
 Why?
Hematopoietic Stem Cell Transplantation
7
2024
577
1.150
 Why?
Combined Modality Therapy
22
2024
1201
1.110
 Why?
Whole-Body Irradiation
2
2024
76
1.050
 Why?
Radiotherapy, Adjuvant
7
2024
208
1.040
 Why?
Prognosis
22
2023
3773
1.000
 Why?
Rhabdomyosarcoma
2
2024
64
0.980
 Why?
Positron-Emission Tomography
8
2024
282
0.960
 Why?
Neoplasms
4
2024
2454
0.960
 Why?
Sarcoma, Ewing
2
2024
87
0.950
 Why?
Disease Progression
7
2024
2628
0.910
 Why?
Humans
109
2025
129847
0.880
 Why?
Radiation
2
2020
23
0.850
 Why?
Craniopharyngioma
1
2024
74
0.840
 Why?
Radiation Exposure
1
2023
45
0.830
 Why?
Hematologic Neoplasms
1
2025
141
0.810
 Why?
Pituitary Neoplasms
1
2024
180
0.800
 Why?
Adenocarcinoma
3
2014
893
0.800
 Why?
Lymphoma, Follicular
5
2020
40
0.780
 Why?
Salivary Glands
2
2021
30
0.760
 Why?
Retrospective Studies
38
2024
14553
0.760
 Why?
Smiling
1
2021
6
0.760
 Why?
Xerostomia
1
2021
17
0.730
 Why?
Tooth Abnormalities
1
2021
12
0.730
 Why?
Brachytherapy
1
2021
104
0.700
 Why?
Young Adult
32
2025
12467
0.680
 Why?
Chemoradiotherapy
9
2021
208
0.680
 Why?
Proton Therapy
1
2020
12
0.680
 Why?
Face
1
2021
165
0.670
 Why?
Child
21
2025
20962
0.660
 Why?
Aged
41
2020
22107
0.650
 Why?
Aged, 80 and over
21
2020
7066
0.640
 Why?
Doxorubicin
12
2020
329
0.640
 Why?
Intraocular Lymphoma
2
2016
3
0.640
 Why?
Middle Aged
49
2024
31177
0.630
 Why?
Bleomycin
8
2020
243
0.610
 Why?
Rectal Neoplasms
3
2016
134
0.610
 Why?
Lymphoma, B-Cell, Marginal Zone
4
2019
12
0.610
 Why?
Adult
51
2024
35634
0.590
 Why?
Cerebellar Neoplasms
1
2020
150
0.590
 Why?
Vinblastine
8
2020
70
0.580
 Why?
Dacarbazine
8
2020
93
0.580
 Why?
Medulloblastoma
1
2020
191
0.570
 Why?
Recurrence
9
2020
1013
0.550
 Why?
Leukemia, Myeloid, Acute
2
2023
596
0.530
 Why?
Leukemia, Biphenotypic, Acute
1
2016
3
0.530
 Why?
Meningeal Neoplasms
1
2018
94
0.530
 Why?
Cancer Survivors
1
2021
257
0.520
 Why?
Adolescent
26
2025
20451
0.520
 Why?
Patient Satisfaction
1
2020
639
0.510
 Why?
Head and Neck Neoplasms
1
2021
544
0.500
 Why?
Female
56
2024
68829
0.500
 Why?
Breast Neoplasms
5
2019
2104
0.490
 Why?
Treatment Outcome
25
2024
10241
0.490
 Why?
Graft vs Host Disease
2
2024
240
0.490
 Why?
Brain Neoplasms
3
2023
1149
0.490
 Why?
Eye Diseases
1
2016
82
0.480
 Why?
Survival Rate
12
2021
1872
0.460
 Why?
Male
50
2024
63759
0.450
 Why?
Disease-Free Survival
12
2020
647
0.440
 Why?
Follow-Up Studies
15
2020
4896
0.440
 Why?
Consensus
4
2024
622
0.440
 Why?
Glycolysis
3
2023
314
0.430
 Why?
Endometrium
1
2013
56
0.420
 Why?
Peritoneal Cavity
1
2013
31
0.420
 Why?
Stomach Neoplasms
3
2019
97
0.410
 Why?
Digestive System Surgical Procedures
1
2014
98
0.410
 Why?
Lymphoma, B-Cell
3
2021
103
0.410
 Why?
Palate, Hard
1
2012
5
0.410
 Why?
Infertility, Female
1
2013
102
0.400
 Why?
Chemoradiotherapy, Adjuvant
3
2019
41
0.400
 Why?
Image Enhancement
1
2013
168
0.390
 Why?
Mastectomy, Simple
1
2012
1
0.390
 Why?
Neoadjuvant Therapy
2
2016
379
0.390
 Why?
Carcinoma, Lobular
1
2012
47
0.370
 Why?
Sentinel Lymph Node Biopsy
1
2012
108
0.370
 Why?
Carcinoma, Ductal, Breast
1
2012
80
0.370
 Why?
Adrenal Gland Neoplasms
1
2012
83
0.360
 Why?
Organs at Risk
3
2020
31
0.350
 Why?
Disease Management
6
2019
592
0.330
 Why?
Tomography, X-Ray Computed
7
2023
2511
0.330
 Why?
Biopsy
6
2020
1089
0.330
 Why?
Radiotherapy, Image-Guided
3
2019
34
0.320
 Why?
Cellulitis
1
2009
49
0.320
 Why?
Kaplan-Meier Estimate
7
2020
851
0.300
 Why?
Carcinoma, Squamous Cell
1
2014
628
0.300
 Why?
Lymphocytes
3
2020
377
0.300
 Why?
Lymphoma, Mantle-Cell
2
2019
19
0.290
 Why?
Multiple Myeloma
2
2020
125
0.290
 Why?
Survival Analysis
6
2020
1271
0.260
 Why?
Cardiotoxicity
2
2023
33
0.260
 Why?
Pregnancy Complications, Neoplastic
2
2017
52
0.260
 Why?
Patient Selection
2
2022
660
0.260
 Why?
Testicular Neoplasms
2
2018
102
0.250
 Why?
Radiation Pneumonitis
2
2016
28
0.250
 Why?
Heart
3
2018
645
0.240
 Why?
Lymph Node Excision
2
2019
164
0.230
 Why?
Child, Preschool
5
2024
10522
0.230
 Why?
Risk Assessment
6
2023
3269
0.230
 Why?
Antimetabolites, Antineoplastic
2
2017
91
0.230
 Why?
Magnetic Resonance Imaging
4
2019
3397
0.230
 Why?
Leukemia
2
2017
230
0.230
 Why?
Transplantation, Haploidentical
1
2024
21
0.220
 Why?
Central Nervous System
3
2021
256
0.220
 Why?
Mediastinum
3
2019
24
0.220
 Why?
Risk Factors
5
2021
9801
0.210
 Why?
Lymphatic Metastasis
3
2014
320
0.210
 Why?
Antineoplastic Agents
5
2024
2045
0.210
 Why?
Lymphadenopathy
1
2023
9
0.210
 Why?
Cord Blood Stem Cell Transplantation
1
2024
99
0.210
 Why?
Transplantation Conditioning
1
2024
166
0.210
 Why?
Neoplasm Grading
4
2019
283
0.200
 Why?
Remission Induction
3
2018
274
0.200
 Why?
Postoperative Complications
1
2014
2481
0.200
 Why?
Protons
2
2020
82
0.190
 Why?
Cohort Studies
6
2024
5444
0.190
 Why?
Brain Stem Neoplasms
1
2023
81
0.190
 Why?
Bone Neoplasms
1
2024
229
0.190
 Why?
Chemotherapy, Adjuvant
2
2013
377
0.190
 Why?
Radiometry
2
2019
48
0.190
 Why?
Gastric Mucosa
2
2019
53
0.190
 Why?
Transplantation, Autologous
3
2018
213
0.190
 Why?
Survivors
2
2023
464
0.190
 Why?
Mitogen-Activated Protein Kinase 7
1
2021
21
0.190
 Why?
Multimodal Imaging
3
2017
110
0.180
 Why?
Poly(ADP-ribose) Polymerases
1
2021
94
0.180
 Why?
Radium
1
2020
3
0.180
 Why?
Breath Holding
2
2017
7
0.180
 Why?
Long Term Adverse Effects
1
2020
12
0.170
 Why?
Cranial Irradiation
2
2023
67
0.170
 Why?
Lung Neoplasms
2
2024
2344
0.170
 Why?
Stem Cell Transplantation
2
2018
166
0.160
 Why?
Clinical Trials as Topic
1
2024
1005
0.160
 Why?
Cardiology
1
2022
266
0.160
 Why?
Postoperative Care
2
2019
244
0.160
 Why?
Skin Neoplasms
2
2018
830
0.160
 Why?
Plasmacytoma
1
2019
16
0.160
 Why?
Radiation Dosage
1
2020
154
0.160
 Why?
CD4-CD8 Ratio
1
2018
22
0.160
 Why?
Glioma
1
2023
351
0.150
 Why?
Mycosis Fungoides
1
2018
61
0.150
 Why?
Methotrexate
2
2017
249
0.150
 Why?
Electrons
1
2018
77
0.150
 Why?
Breast Neoplasms, Male
1
2018
28
0.150
 Why?
Area Under Curve
1
2019
306
0.150
 Why?
Peritoneal Neoplasms
1
2019
86
0.150
 Why?
Radiotherapy Setup Errors
1
2017
3
0.140
 Why?
Platelet Count
1
2017
82
0.140
 Why?
Autografts
1
2018
42
0.140
 Why?
Hypothyroidism
1
2018
70
0.140
 Why?
Craniospinal Irradiation
1
2017
5
0.140
 Why?
Dendritic Cell Sarcoma, Follicular
1
2017
2
0.140
 Why?
Eye Neoplasms
1
2017
16
0.140
 Why?
Vincristine
4
2019
108
0.140
 Why?
Leukocyte Count
1
2017
326
0.130
 Why?
Uncertainty
1
2017
122
0.130
 Why?
Osteogenesis Imperfecta
2
2007
13
0.130
 Why?
Spinal Cord Diseases
1
2017
41
0.130
 Why?
Pentostatin
1
2016
1
0.130
 Why?
Neoplasm, Residual
1
2017
121
0.130
 Why?
Axilla
2
2017
46
0.130
 Why?
Photopheresis
1
2016
9
0.130
 Why?
Predictive Value of Tests
3
2022
1951
0.130
 Why?
Methylprednisolone
1
2016
83
0.130
 Why?
Collagen Type I
2
2007
118
0.130
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
99
0.130
 Why?
Plasmablastic Lymphoma
1
2015
7
0.130
 Why?
Confidence Intervals
1
2016
318
0.120
 Why?
Antibiotics, Antineoplastic
1
2016
123
0.120
 Why?
Anxiety
1
2023
976
0.120
 Why?
Congenital Abnormalities
1
2016
76
0.120
 Why?
Abortion, Spontaneous
1
2016
100
0.120
 Why?
Drug Resistance, Neoplasm
2
2019
753
0.120
 Why?
Fatal Outcome
1
2016
300
0.120
 Why?
Hysterectomy
2
2013
118
0.120
 Why?
Proportional Hazards Models
4
2020
1199
0.120
 Why?
Transplantation, Homologous
1
2016
402
0.120
 Why?
Coronary Artery Disease
1
2021
680
0.120
 Why?
Tacrolimus
1
2016
193
0.120
 Why?
Blood Platelets
1
2017
386
0.110
 Why?
Biomarkers
4
2021
3971
0.110
 Why?
Risk
1
2016
860
0.110
 Why?
Age Factors
1
2021
3161
0.110
 Why?
Etoposide
3
2018
148
0.110
 Why?
Receptors, Progesterone
2
2014
341
0.110
 Why?
Kidney Neoplasms
1
2018
347
0.110
 Why?
Cyclophosphamide
3
2019
234
0.110
 Why?
Receptor, ErbB-2
2
2014
325
0.100
 Why?
Rituximab
3
2019
164
0.100
 Why?
Caregivers
1
2020
809
0.100
 Why?
Spinal Cord
1
2015
355
0.100
 Why?
Carboplatin
1
2013
139
0.100
 Why?
Receptors, Estrogen
2
2014
422
0.100
 Why?
Lung
2
2016
3940
0.100
 Why?
Carcinoma, Non-Small-Cell Lung
1
2021
1050
0.100
 Why?
Anti-Inflammatory Agents
1
2016
482
0.100
 Why?
Pelvis
1
2013
104
0.100
 Why?
Fluorouracil
1
2013
197
0.100
 Why?
Radiotherapy, Conformal
1
2012
69
0.100
 Why?
Paclitaxel
1
2013
218
0.100
 Why?
Neutrophils
1
2017
1209
0.100
 Why?
Health Knowledge, Attitudes, Practice
1
2020
1284
0.090
 Why?
Immunoenzyme Techniques
1
2012
211
0.090
 Why?
Immunohistochemistry
1
2016
1690
0.090
 Why?
Immunosuppressive Agents
1
2016
858
0.090
 Why?
Cisplatin
1
2013
299
0.090
 Why?
Brain
2
2020
2677
0.090
 Why?
Immunotherapy
1
2015
596
0.090
 Why?
Triple Negative Breast Neoplasms
1
2014
193
0.090
 Why?
Models, Biological
1
2018
1724
0.090
 Why?
Contrast Media
1
2013
394
0.090
 Why?
Liver Neoplasms
1
2014
636
0.080
 Why?
Prospective Studies
3
2021
7158
0.080
 Why?
Patient Compliance
1
2013
568
0.080
 Why?
Polymorphism, Single Nucleotide
1
2016
2062
0.080
 Why?
Dose-Response Relationship, Radiation
2
2020
133
0.080
 Why?
Antibodies, Monoclonal, Murine-Derived
2
2019
86
0.070
 Why?
United States
2
2021
13913
0.070
 Why?
Biomarkers, Tumor
1
2014
1161
0.070
 Why?
Prednisone
2
2019
234
0.070
 Why?
Colorectal Neoplasms
1
2014
748
0.070
 Why?
Cytarabine
2
2018
57
0.070
 Why?
Time Factors
4
2018
6550
0.070
 Why?
Practice Guidelines as Topic
1
2014
1514
0.070
 Why?
Proteoglycans
1
2007
109
0.060
 Why?
Integrins
1
2007
94
0.060
 Why?
Treatment Failure
2
2018
339
0.060
 Why?
Glycine
1
2006
166
0.060
 Why?
Amino Acid Substitution
1
2006
284
0.060
 Why?
Clinical Decision-Making
2
2019
304
0.060
 Why?
Neoplasm Invasiveness
2
2017
484
0.060
 Why?
X-ray Repair Cross Complementing Protein 1
1
2023
12
0.050
 Why?
Intelligence Tests
1
2023
57
0.050
 Why?
Standard of Care
1
2024
71
0.050
 Why?
X-Rays
1
2023
26
0.050
 Why?
Cell- and Tissue-Based Therapy
1
2024
77
0.050
 Why?
Regression Analysis
2
2016
998
0.050
 Why?
Proto-Oncogene Proteins c-sis
1
2023
35
0.050
 Why?
Terminology as Topic
1
2024
204
0.050
 Why?
Inducible T-Cell Co-Stimulator Protein
1
2022
9
0.050
 Why?
Analysis of Variance
2
2016
1291
0.050
 Why?
Phenotype
3
2021
3062
0.050
 Why?
Cytidine Deaminase
1
2023
57
0.050
 Why?
Brain Stem
1
2023
100
0.050
 Why?
Ribose
1
2021
22
0.050
 Why?
Radiosurgery
1
2024
321
0.050
 Why?
Adenosine Diphosphate
1
2021
81
0.050
 Why?
Poly (ADP-Ribose) Polymerase-1
1
2021
42
0.050
 Why?
Troponin T
1
2021
57
0.040
 Why?
Feedback
1
2021
163
0.040
 Why?
Immunotherapy, Adoptive
1
2024
300
0.040
 Why?
Automation
1
2020
81
0.040
 Why?
Neoplasms, Radiation-Induced
1
2020
71
0.040
 Why?
Prevalence
2
2016
2564
0.040
 Why?
Risk Management
1
2020
92
0.040
 Why?
Incidence
2
2016
2646
0.040
 Why?
Neoplasms, Second Primary
1
2020
106
0.040
 Why?
Workflow
1
2020
157
0.040
 Why?
Neuropsychological Tests
1
2023
1016
0.040
 Why?
Mesentery
1
2019
47
0.040
 Why?
Safety
1
2020
335
0.040
 Why?
Busulfan
1
2018
15
0.040
 Why?
Melphalan
1
2018
29
0.040
 Why?
Respiration
1
2019
193
0.040
 Why?
Carmustine
1
2018
50
0.040
 Why?
Inhalation
1
2017
28
0.040
 Why?
Cone-Beam Computed Tomography
1
2017
30
0.040
 Why?
Breast
1
2018
140
0.030
 Why?
Time-to-Treatment
1
2019
179
0.030
 Why?
Subacute Combined Degeneration
1
2017
1
0.030
 Why?
Photons
1
2017
67
0.030
 Why?
Phosphorylation
1
2021
1716
0.030
 Why?
Organ Sparing Treatments
1
2017
32
0.030
 Why?
Deoxycytidine
1
2018
164
0.030
 Why?
Orbit
1
2017
58
0.030
 Why?
Injections, Spinal
1
2017
111
0.030
 Why?
Lymph Nodes
1
2019
471
0.030
 Why?
New York
1
2016
128
0.030
 Why?
Homocysteine
1
2017
152
0.030
 Why?
Procarbazine
1
2015
8
0.030
 Why?
Mutation
1
2007
3706
0.030
 Why?
Transforming Growth Factor beta1
1
2016
158
0.030
 Why?
Observer Variation
1
2016
314
0.030
 Why?
Genetic Markers
1
2016
334
0.030
 Why?
Animals
2
2021
35409
0.030
 Why?
Folic Acid
1
2017
182
0.030
 Why?
Texas
1
2016
237
0.030
 Why?
Mitochondria
1
2021
875
0.030
 Why?
Secondary Prevention
1
2016
220
0.030
 Why?
Molecular Targeted Therapy
1
2018
391
0.030
 Why?
Gastrointestinal Diseases
1
2016
198
0.030
 Why?
Pregnancy Outcome
1
2017
392
0.030
 Why?
Diagnostic Imaging
1
2017
326
0.030
 Why?
Abortion, Induced
1
2016
100
0.030
 Why?
Pregnancy
2
2017
6423
0.030
 Why?
Drug Administration Schedule
1
2016
766
0.030
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
279
0.030
 Why?
Acute Disease
1
2016
980
0.030
 Why?
Postpartum Period
1
2016
331
0.030
 Why?
Mastectomy
1
2014
132
0.030
 Why?
CD8-Positive T-Lymphocytes
1
2018
855
0.020
 Why?
Ultrasonography
1
2016
713
0.020
 Why?
Multivariate Analysis
1
2016
1501
0.020
 Why?
Diagnosis, Differential
1
2017
1434
0.020
 Why?
CD4-Positive T-Lymphocytes
1
2018
1058
0.020
 Why?
Medical Oncology
1
2014
268
0.020
 Why?
Ovariectomy
1
2012
137
0.020
 Why?
Comorbidity
1
2016
1551
0.020
 Why?
Severity of Illness Index
1
2019
2739
0.020
 Why?
Quality of Life
1
2021
2695
0.020
 Why?
Electronic Health Records
1
2017
979
0.020
 Why?
Kidney
1
2017
1383
0.020
 Why?
Diet
1
2017
1212
0.020
 Why?
Reproducibility of Results
1
2016
3089
0.020
 Why?
Anti-Bacterial Agents
1
2019
1708
0.020
 Why?
Genetic Predisposition to Disease
1
2016
2271
0.020
 Why?
Infant
1
2020
9018
0.020
 Why?
Electrophoresis
1
2006
31
0.020
 Why?
Case-Control Studies
1
2014
3384
0.020
 Why?
DNA Mutational Analysis
1
2007
379
0.020
 Why?
Databases, Genetic
1
2007
228
0.020
 Why?
Collagen
1
2007
438
0.010
 Why?
Protein Structure, Tertiary
1
2007
844
0.010
 Why?
Mice
1
2021
16983
0.010
 Why?
Binding Sites
1
2007
1251
0.010
 Why?
Protein Binding
1
2007
2123
0.010
 Why?
Cells, Cultured
1
2006
4102
0.010
 Why?
Milgrom's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (347) concept(s)
_
Co-Authors Expand Description
See all (36) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)